BENZYL BROMOACETATE
General Information
Mainterm | BENZYL BROMOACETATE |
CAS Reg.No.(or other ID) | 5437-45-6 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 62576 |
IUPAC Name | benzyl 2-bromoacetate |
InChI | InChI=1S/C9H9BrO2/c10-6-9(11)12-7-8-4-2-1-3-5-8/h1-5H,6-7H2 |
InChI Key | JHVLLYQQQYIWKX-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)COC(=O)CBr |
Molecular Formula | C9H9BrO2 |
Wikipedia | benzyl bromoacetate |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 229.073 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Complexity | 142.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B w M A A A E A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g B A A A A B T A C g m A I w C I A A B A C I A i D S C A A C A A A g A A A I i A A A C I g o J i K A M R i C M A A k w A E I q A e A w C A O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 26.3 |
Monoisotopic Mass | 227.979 |
Exact Mass | 227.979 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9737 |
Human Intestinal Absorption | HIA+ | 0.9943 |
Caco-2 Permeability | Caco2+ | 0.7419 |
P-glycoprotein Substrate | Non-substrate | 0.7941 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9468 |
Non-inhibitor | 0.9610 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8006 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7739 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8538 |
CYP450 2D6 Substrate | Non-substrate | 0.9135 |
CYP450 3A4 Substrate | Non-substrate | 0.7805 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6745 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8038 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9308 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6286 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9292 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6981 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9358 |
Non-inhibitor | 0.9377 | |
AMES Toxicity | AMES toxic | 0.5280 |
Carcinogens | Non-carcinogens | 0.5273 |
Fish Toxicity | High FHMT | 0.8803 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9989 |
Honey Bee Toxicity | High HBT | 0.7179 |
Biodegradation | Not ready biodegradable | 0.6177 |
Acute Oral Toxicity | III | 0.6724 |
Carcinogenicity (Three-class) | Non-required | 0.4028 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.7559 | LogS |
Caco-2 Permeability | 1.6483 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 3.1493 | LD50, mol/kg |
Fish Toxicity | 0.0729 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.8321 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Benzene and substituted derivatives |
Subclass | Benzyloxycarbonyls |
Intermediate Tree Nodes | Not available |
Direct Parent | Benzyloxycarbonyls |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | Benzyloxycarbonyl - Alpha-halocarboxylic acid derivative - Alpha-halocarboxylic acid or derivatives - Carboxylic acid ester - Carboxylic acid derivative - Monocarboxylic acid or derivatives - Alkyl bromide - Organohalogen compound - Organobromide - Organooxygen compound - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organic oxygen compound - Alkyl halide - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as benzyloxycarbonyls. These are organic compounds containing a carbonyl group substituted with a benzyloxyl group. |
From ClassyFire